Enhance Anti-obesity Effect of Natural Compounds through Carrier Mediation

Mingyue Peng1, Hao Wang1, Zhenjing Liu1

  • 1Department of Biopharmaceutical Science, Shanghai Ocean University, Hucheng Ring Road, Shanghai, 201306, China.

PubMed

Insights

Emerging obesity treatments leverage natural compounds delivered via advanced carriers for targeted therapy. This review explores their potential to overcome limitations of current anti-obesity drugs.

Area of Science:

  • Pharmacology and Materials Science
  • Biomedical Engineering
  • Public Health

Background:

  • Obesity is a global health crisis with severe comorbidities.
  • Current anti-obesity medications have limitations including bioavailability, specificity, and toxicity.
  • There is a critical need for novel and safer obesity treatment strategies.

Purpose of the Study:

  • To review the current status and challenges of natural compounds in obesity treatment.
  • To summarize the advanced functions and prospects of carrier delivery systems for natural obesity treatments.
  • To explore the application of these novel strategies in preclinical and clinical research.

Main Methods:

  • Systematic review of existing literature on natural compounds and drug delivery systems for obesity.
  • Analysis of emerging obesity treatment strategies integrating materials science and natural product chemistry.
  • Evaluation of preclinical and clinical research data on carrier-mediated delivery of natural anti-obesity agents.

Main Results:

  • Natural compounds show promise as alternatives to conventional anti-obesity drugs.
  • Carrier delivery systems enhance the targeted delivery and efficacy of natural ingredients.
  • Emerging strategies offer potential solutions to overcome limitations of current obesity pharmacotherapies.

Conclusions:

  • Carrier-mediated delivery of natural compounds represents a promising frontier in obesity treatment.
  • Further research is needed to address challenges in targeted delivery and clinical translation.
  • Multidisciplinary approaches are essential for developing next-generation anti-obesity therapies.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
247
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
3.5K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
173
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
114
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K